FluMist nasal spray poised for a return |

FluMist nasal spray poised for a return

FILE - In this Oct. 4, 2005 file photo, Amanda Klopfer reacts as she is given a FluMist influenza vaccination in St. Leonard, Md. On Wednesday, Feb. 21, 2018, a federal panel says it's OK for doctors to start using the kid-friendly nasal spray flu vaccine again. (AP Photo/Chris Gardner, File)

FluMist, the nasal flu vaccine pulled two years ago, is poised to make a comeback when flu season resumes in October.

The Advisory Committee on Immunization Practices, which provides advice and guidelines of vaccine-preventable diseases in the United States, voted to recommend placing the nasal spray on the Centers for Disease and Control and Prevention’s list of recommended vaccines.

The catch, however, is that flu vaccines are usually manufactured six months before flu season hits so its not known how much of an impact this will have. Influenza kills about 36,000 people a year on average, according to the CDC. So far, the virus has been a contributing factor in the deaths of 135 people in Pennsylvania, including 17 in Allegheny County.

Flu shots do not contain the flu virus. The nasal vaccine, however, does contain a weakened version of the flu. FluMist was pulled two years ago because there was a question about its effectiveness.

The idea behind the nasal vaccine is that the body will launch an immune response to fight the flu virus, which has been diluted to the point that it will not cause an infection. If FluMist was available, then more needle-phobic people and children might get vaccinated, doctors said.

“Other countries use FluMist,” said Dr. Amesh Adalja, a Pittsburgh physician who is an infectious disease expert for the Johns Hopkins Center for Health Security. “We want to have as many options as possible.”

Dr. Joseph Aracri, chairof pediatrics at Allegheny Health Network, said he saw 25 to 30 percent less children get a flu vaccination when FluMist was taken out of rotation.

“FluMist has ease of delivery and is a fine mist,” Aracri said. “It has been effective in the past.”

Suzanne Elliott is a Tribune-Review staff writer. She can be reached at 412-871-2346 or [email protected] or via Twitter @41Suzanne

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.